With syphilis rates on the rise, a reverse screening algorithm offers high clinical value
The CDC provides a suggested algorithm for labs wishing to adopt a reverse screening approach for syphilis testing. Reverse screening uses a treponemal test as the initial assay and reactive results are confirmed using nontreponemal methods.1,2 Adoption of a reverse algorithm can improve both clinical detection and workflow if using a sensitive, automated treponemal test.3,4
Siemens Healthineers offers a sensitive treponemal Syphilis assay on both the Atellica® IM Analyzer and ADVIA Centaur® systems that can be incorporated into the Reverse Sequence Screening algorithm.
Achieve higher sensitivity in primary and late-latent disease stages by using the CDC-recommended algorithm for Reverse Sequence Syphilis Screening.2
- Receive results quickly with a treponemal antibody test that has good precision and good agreement with a comparative automated syphilis assay.
- Detect true positives with good sensitivity and reduce false positives with good specificity.
- Consolidate syphilis testing with other high-volume ID, TORCH, and routine assays on one system to improve lab productivity.